Meeting
2022 ASCO Gastrointestinal Cancers Symposium
Characteristics and outcomes of patients with multiple synchronous colon cancer primaries.
Authors
Maria Diab
Department of Hematology and Medical Oncology, Winship Cancer Institute of Emory University, Atlanta, GA
Maria Diab , Subir Goyal , Jeffrey M. Switchenko , Olatunji B. Alese , Walid Labib Shaib , Mehmet Akce , Christina Wu , Bassel F. El-Rayes
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session C: Cancers of the Colon, Rectum, and Anus
Track
Colorectal Cancer,Anal Cancer
Sub Track
Tumor Biology, Biomarkers, and Pathology
DOI
10.1200/JCO.2022.40.4_suppl.194
Abstract #
194
Poster Bd #
Online Only
Abstract Disclosures
Similar Posters
Poster
2020 Gastrointestinal Cancers Symposium
CD3+ tumor-infiltrating lymphocytes (TILs) as prognostic in patients (pts) with stage II colon cancer (CC) not treated with adjuvant chemotherapy (ADJ).
First Author: Edoardo Francini
Poster
2020 Gastrointestinal Cancers Symposium
The influence of adjuvant chemotherapy dose intensity on overall survival in resected colon cancer: A multicenter retrospective analysis.
First Author: Suganija Lakkunarajah
Poster
2020 Gastrointestinal Cancers Symposium
Circulating tumor DNA-based decision for adjuvant treatment in colon cancer stage II evaluation: (CIRCULATE-trial) AIO-KRK-0217.
First Author: Gunnar Folprecht
Poster
2019 Gastrointestinal Cancers Symposium
Outcomes and utilization of adjuvant chemotherapy (AT) for stage II colon cancer (CC-II) in elderly population.
First Author: Afsaneh Barzi